ANEXO APDA

Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG, Rapoport JL, Berg K, Bailey-
Wilson JE, Muenke M. (2004). Attention-Deficit/Hyperactivity Disorder in a Population Isolate: Linkage to Loci at 4q13.2, 5q33.3, 11g22, and 17p11. Am J Hum Genetics. 75: 998-1014.

Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ et al. (2003).A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet. 72:1251-1260.

Barker DJO, Osmond C, Winter PD, Margetts B and Simmonds SJ. (1989). Weight in infancy and death from ischaemic heart disease. Lancet. 2:577-580.

Bax M and McKeith RM, eds. Minimal Cerebral Dysfunctions. Clinics in Developmental Medicine. Lavenham, Suffolk: The Lavenham Press LTD, 1962.

Bellgrove MA, Hawi Z, Lowe N, Kirley A, Robertson IH and H Gill. (2005). DRD4 gene variants and sustained attention in ADHD: effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet B Neuropsychiatr Genet. 136:81-6.

Braun J, Kahn RS, Froehlich T, Aulnger P and BP Lanphear. (2006). Exposures to Environmental Toxicants and Attention Deficit Hyperactivity Disorder in US Children. Environmental Health Perspectives. 114:1904-9.

Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Aneey R, Franke B, Gill M, Ebstein R, Buitelaar J, Sham P, Campbell D, Knight J, Andreou P, Altink A, Amold R, Boer F, Buschgens et al. (2006). The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Molecular Psychiatry. 11: 934-953.

Brookes KJ, Mill J, Guindalini C, Curran S, Xu, X, Knight J, Chen CK, Huang YS, Sethna V, Taylor E, Chen W, Breen G, Asherson P. (2006). A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry. 63: 74-81.

Carrasco X, Rothhammer P, Moraga M, Henriquez H, Chakraborty R, Aboitiz F, Rothhammer F (2006).
Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for ADHD in Chilean families.Am J Med Genet B Neuropsychiatr Genet. 141:51-4

Cook EH, Jr., Stein MA, Krasowski MD, Cox, NJ, Olkon DM, Kieffer JE, et al. (1995). Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet. 56:993-998.

Crowe RR. (1993). Candidate genes in psychiatry: an epidemiological perspective. Am J Med Genet. 48:74-77.
Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL et al.(2002). A genome wide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet. 70:1183-1196.

Gillman M. (2005). Developmental Origins of Health and Disease. New England Journal of Medicine. 353:1848-50.

Gluckman PD and MA Hanson. (2004). Living with the Past: Evolution, Development, and Patterns of Disease. Science. 305: 1733-6.

Hutz MH, Almeida S, Coimbra CE Jr, Santos RV, Salzano FM. (2000). Haplotype and allele frequencies for three genes of the dopaminergic system in South American Indians.Am J Hum Biol. 12:638-645

Kahn RS, Khoury J, Nichols WC, Lanphear BP. (2003). Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatrics. 143: 104_110.

Kieling C, Roman T, Doyle AE, Hutz MH, Rohde LA. (2006). Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry.10:1163-5.

Knopik VS, Health AC, Jacob T, Slutske WS, Bucholz KK, Madden PAF, Walron M, Martin NG. (2006). Maternal alcohol use disorder and offspring ADHD: disentangling genetic and environmental effects using a children-of-twins design. Psychological Medicine. 36: 1461-1471.

Konrad K, Gauggel S, Schurek J. (2003). Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder.Brain Res Cogn Brain Res. 16:425-33.

LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL. (1996). Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry. 1:121-124.

Landrigan PJ, Trasande L, Thorpe LE, Gwynn C, Lioy PJ, D'Alton ME, Lipkind HS, Swanson J, Wadhwa PD,
Clark EB, Rauh VA, Perera FP, Susser E. (2006). The National Children's Study: a 21-year prospective study of 100,000 American children. Pediatrics 118:2173-86.

Langley K, Marshall L, van den Bree M, Thomas H, Owen M, O'Donovan M et al. (2004). Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psych 161:133-138.

Leung PWL, Lee CC, Hung SF, Ho TP, Tang CP, Kwong SL, Leung SY, Yuen ST, Lieh-Mak F, Oosterlaan J, Grady D, Harxhi A, Ding YC, Chi HC, Flodman P, Shuck S, Spence MA, Moyzis R, Swanson JM. (2005). Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention deficit/hyperactivity disorder (ADHD): Increased prevalence of the 2-repeat allele. Am J Med Genet B Neuropsychiatr Genet 133(1):54-6.

Levy F. (1991). The dopamine theory of attention deficit hyperactivity disorder (ADHD). Australian and New Zealand Journal of Psychiatry. 25:277-283.

Li D, Sham PC, Owen MJ, He L. (2006). Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet. 15: 2276-84.

Linett K, Dalsgaard S, Obel C, Wisbord K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J, Jarvelin M. (2005). Maternal Lifestyle Factors in Pregnancy Risk of Attention Deficit Hyperactivity Disorder and Associated Behaviors: Review of the Current Evidence. Am J Psychiatry. 160:1026-1040.

Linett KM, Wisborg K, Agerbo E, Sechor NJ, Thomsen PH, Henriksen TB. (2006).Gestational age, birth weight, and the risk of hyperkinetic disorder. Arch Dis Child. 91:655-60.

Lou HC. (1996). Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxis-haemodynamic encephalophy. Acta Paediatr. 85: 1266-1271.

Manor I, Tyano S, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP. (2002). The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry. 7:790-794.

Millberger S, Biederman J, Faraone SV, Chen L, Jones L. (1996). Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry. 153: 1138-1142.

Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. (2002). Case-Control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug-use during pregnancy. J Am Acad Child Adolesc Psychiatry. 41:378-85.

Neto P, Lou H, Cumming P, Pryds O, Gjedde A. (2002). Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth. Ann N Y Acad Sci. 965:434-439.

Ogdie M, Macphie IL, Minassian SL, Yang M, Fisher SE, Francis CF, Cantor RM, MacCracken JT, McGough JJ, Nelson SF, Monaco AP, Smalley SL. (2003). A genome wide scan for attention-deficit/hyperactivity disorder: suggestive linkage on 17p11. Am J Hum Genet. 72:1268-1279.

Rohde LA, Szobot C, Polanczyk G, Schmitz M, Martins S, Tramontina S. (2005). Attention-deficit/hyperactivity disorder in a diverse culture: do research and clinical findings support the notion of a cultural construct for the disorder? Biol Psychiatry 57:1436-41.

Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. (2001). Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet. 105:471-8.

Schmitz M, Denardin D, Laufer Silva T, Pianca T, Hutz MH, Faraone S, Rohde LA. (2006). Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. J Am Acad Child Adolesc Psychiatry. 11:1338-45.

Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S. (1998). Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Molecular Psychiatry, 3(1):38-41.

Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos G, Volkow N, Taylor E, Casey BJ, Castellanos FX, and Wadhwa. (2007). Etiologic Subtypes of ADHD: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis. Neuropsychology Review 17: 39-59.

Taylor E and Rogers JW. (2005). Practitioner review: early adversity and developmental disorders. J Child Psychology and Psychiatry. 46: 451-467.

Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. (1995). Arch Gen Psychiatry; 52:456-463.

Wang E, Ding YC, Flodman P, Kidd JR, Kidd KK, Grady DL, Ryder OA, Spence MA, Swanson JM, Moyzis RK. (2004). The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am J Hum Genet 74(5):931-944.

Wender P. (1971). Minimal brain dysfunction in children. New York: Wiley-Liss.

Wigal SB, Nemet D, Swanson JM, Regino R, Trampush J, Ziegler MG, Cooper DM. (2003). Catecholamine response to exercise in children with attention deficit hyperactivity disorder. Pediatr Res, 53(5):756-761.